Jaguar Health (JAGX) Asset Writedowns and Impairment (2019)
Jaguar Health (JAGX) reported Asset Writedowns and Impairment of $4.0 million for Q2 2019.
Jaguar Health (JAGX) Asset Writedowns and Impairment (2019) Analysis & Trends
Jaguar Health (JAGX) has 1 years of Asset Writedowns and Impairment data on file, last reported at $4.0 million in Q2 2019.
- Asset Writedowns and Impairment for Q2 2019 came in at $4.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2020 was $4.0 million (changed 0.0% YoY), and the FY2025 annual result was $800000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment was little changed at $4.0 million in Q2 2019 per JAGX's latest filing.
- Over five years, Asset Writedowns and Impairment peaked at $4.0 million in Q2 2019 and troughed at $4.0 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 4.00 Mn |
| Jun 30, 2019 | 4.00 Mn |